The senior NITI Aayog member, VK Paul announced on Tuesday that the phase II/III clinical trials will begin in 10-12 days. The trials will be for the children ageing between 2 to 18 years. The Health Ministry said that proposal was initiated in Subject Expert Committee (SEC) on May 11. India gave clearance to the Covaxin trials on May 13.
Dr. VK Paul, a member of the health NITI Aayog said,”COVAXIN has been approved by the Drugs Controller General of India (DCGI), for phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days”. The trial will be done in 525 subjects at various sites.
Covaxin, together with Covishield, is being used to vaccinate adults in the country. The US authorized Pfizer and BioNTech’s vaccine for children ageing from 2 to 15 years last week.
Discussion about this post